The Endocannabinoid Anandamide Protects Neurons during CNS Inflammation by Induction of MKP-1 in Microglial Cells

Translating the Histone Code

Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092

Axonal transection in the lesions of multiple sclerosis

Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913

Determination and characterization of a cannabinoid receptor in rat brain

Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443

Cannabinoid receptor localization in brain.

Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321

2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain

Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196

The molecular logic of endocannabinoid signalling

Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957

Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations

Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D. J., Fur, G. L., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,776

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

Marzo, V. D., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,585

Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty

Vasincu, A., Rusu, R.-N., Ababei, D. C., Larion, M., Bild, W., Stanciu, G. D., Solcan, C., & Bild, V. (2022) · Biology · doi:10.3390/biology11030440 · Cited by 44

Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E2

Correa, F., Docagne, F., Clemente, D., Mestre, L., Becker, C., & Guaza, C. (2008) · Biochemical Journal · doi:10.1042/bj20071329 · Cited by 41

Daphnetin attenuates microglial activation and proinflammatory factor production via multiple signaling pathways

Yu, W., Wang, H., Ying, H., Yu, Y., Chen, D., Ge, W., & Shi, L. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.04.005 · Cited by 40

The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ-tetrahydrocannabinol acting through CB1 receptors

Moreno‐Martet, M., Feliú, A., Espejo‐Porras, F., Mecha, M., Carrillo-Salinas, F. J., Fernández‐Ruíz, J., Guaza, C., & de Lago, E. (2015) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2015.08.001 · Cited by 39

Discovery of a fluorinated 4‐oxo‐quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2

Slavik, R., Herde, A. M., Haider, A., Krämer, S. D., Weber, M., Schibli, R., Ametamey, S. M., & Mu, L. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13716 · Cited by 39

Anti-Inflammatory Effects by Pharmacological Inhibition or Knockdown of Fatty Acid Amide Hydrolase in BV2 Microglial Cells

Tanaka, M., Yagyu, K., Sackett, S., & Zhang, Y. (2019) · Cells · doi:10.3390/cells8050491 · Cited by 41

Synthetic cannabinoids reduce the inflammatory activity of microglia and subsequently improve neuronal survival in vitro

Young, A. P., & Denovan‐Wright, E. M. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.06.011 · Cited by 37

Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System

Pryce, G., & Baker, D. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712801661310 · Cited by 39

Identification of P2Y receptors involved in oleamide-suppressing inflammatory responses in murine microglia and human dendritic cells

Kita, M., Ano, Y., Inoue, A., & Aoki, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-40008-8 · Cited by 38

Cannabinoid receptor subtypes 1 and 2 mediate long-lasting neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia

Schmidt, W., Schäfer, F., Striggow, V., Fröhlich, K., & Striggow, F. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.09.080 · Cited by 39

Steroidogenic Factor 1 Regulates Expression of the Cannabinoid Receptor 1 in the Ventromedial Hypothalamic Nucleus

Kim, K. W., Jo, Y., Zhao, L., Stallings, N. R., Chua, S. C., & Parker, K. L. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0127 · Cited by 38

Early postinjury exercise reverses memory deficits and retards the progression of closed‐head injury in mice

Chen, M., Huang, T., Kuo, Y., Yu, L., Chen, H., & Jen, C. J. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2012.241125 · Cited by 37

New vistas on cannabis use disorder

Melis, M., Frau, R., Kalivas, P. W., Spencer, S. M., Chioma, V. C., Zamberletti, E., Rubino, T., & Parolaro, D. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.03.033 · Cited by 38

A Review of the Effects of Pain and Analgesia on Immune System Function and Inflammation: Relevance for Preclinical Studies

DeMarco, G. J., & Nunamaker, E. A. (2019) · Comparative Medicine · doi:10.30802/aalas-cm-19-000041 · Cited by 39

Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy

Szczesniak, A.-M., Porter, R. F., Toguri, J. T., Borowska-Fielding, J., Gebremeskel, S., Siwakoti, A., Johnston, B., Lehmann, C., & Kelly, M. E. M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.08.030 · Cited by 38

Mitogen-Activated Protein Kinase Phosphatase (MKP)-1 as a Neuroprotective Agent: Promotion of the Morphological Development of Midbrain Dopaminergic Neurons

Collins, L., O’Keeffe, G. W., Long-Smith, C. M., Wyatt, S. L., Sullivan, A. M., Toulouse, A., & Nolan, Y. M. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8230-5 · Cited by 36

Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors

Pryce, G., Cabranes, A., Fernández‐Ruíz, J., Bisogno, T., Marzo, V. D., Long, J. Z., Cravatt, B., Giovannoni, G., & Baker, D. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513485982 · Cited by 37

Costunolide inhibits proinflammatory cytokines and iNOS in activated murine BV2 microglia

Dheen, S. T. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/e312 · Cited by 36

Mitogen Activated Protein Kinase Phosphatase-1 Prevents the Development of Tactile Sensitivity in a Rodent Model of Neuropathic Pain

Ndong, C., Landry, R. P., DeLeo, J. A., & Romero-Sandoval, E. A. (2012) · Molecular Pain · doi:10.1186/1744-8069-8-34 · Cited by 37

Impacts of epidural electrical stimulation on Wnt signaling, FAAH, and BDNF following thoracic spinal cord injury in rat

Ghorbani, M., Shahabi, P., Karimi, P., Zangbar, H. S., Morshedi, M., Bani, S., Jafarzadehgharehziaaddin, M., Oskouei, B. S., & Ahmadalipour, A. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29793 · Cited by 35

Phytocannabinoids and Cannabis-Based Products as Alternative Pharmacotherapy in Neurodegenerative Diseases: From Hypothesis to Clinical Practice

Paes-Colli, Y., Aguiar, A. F. L., Isaac, A. R., Ferreira, B. K., Campos, R. M. P., Trindade, P. M. P., Reis, R. A. D. M., & Sampaio, L. D. S. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.917164 · Cited by 39

Cannabinoid receptor 2 attenuates microglial accumulation and brain injury following germinal matrix hemorrhage via ERK dephosphorylation in vivo and in vitro

Tang, J., Tao, Y., Tan, L., Yang, L. M., Niu, Y., Chen, Q., Yang, Y., Feng, H., Chen, Z., & Zhu, G. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.04.028 · Cited by 36

CB2 Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120

Hu, S., Sheng, W. S., & Rock, R. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077577 · Cited by 34

Endocannabinoid signaling regulates regenerative axon navigation in Caenorhabditis elegans via the GPCRs NPR‐19 and NPR‐32

Pastuhov, S. I., Matsumoto, K., & Hisamoto, N. (2016) · Genes to Cells · doi:10.1111/gtc.12377 · Cited by 33

Changes in CB1 receptors in motor-related brain structures of chronic relapsing experimental allergic encephalomyelitis mice

Cabranes, A., Pryce, G., Baker, D., & Fernández‐Ruíz, J. (2006) · Brain Research · doi:10.1016/j.brainres.2006.06.001 · Cited by 34

The neuroprotective role of endocannabinoids against chemical‐induced injury and other adverse effects

Zogopoulos, P., Vasileiou, I., Patsouris, E., & Theocharis, S. E. (2013) · Journal of Applied Toxicology · doi:10.1002/jat.2828 · Cited by 34

Beneficial and deleterious effects of cannabinoids in the brain: the case of ultra-low dose THC

Sarne, Y. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2019.1578366 · Cited by 34

Cannabinoid receptors as therapeutic targets for autoimmune diseases: where do we stand?

Gonçalves, E. D., & Dutra, R. C. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.05.023 · Cited by 36

Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination

Longoria, V., Parcel, H., Toma, B., Minhas, A., & Zeine, R. R. (2022) · Biomedicines · doi:10.3390/biomedicines10030539 · Cited by 36

Mitogen-Activated Protein Kinase Phosphatase (MKP)-1 in Nervous System Development and Disease

Collins, L., Downer, E. J., Toulouse, A., & Nolan, Y. M. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8786-6 · Cited by 33

Mesoporous Silica Particles as a Multifunctional Delivery System for Pain Relief in Experimental Neuropathy

Xie, J., Xiao, D., Zhao, J., Hu, N., Bao, Q., Jiang, L., & Yu, L. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201500996 · Cited by 34

Endocannabinoids affect innate immunity of Muller glia during HIV-1 Tat cytotoxicity

Krishnan, G., & Chatterjee, N. (2014) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2014.01.001 · Cited by 32

The Development of Cannabinoid CBII Receptor Agonists for the Treatment of Central Neuropathies

Rivers‐Auty, J., & Ashton, J. C. (2010) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/187152410790780145 · Cited by 32

Visualization of 2‐arachidonoylglycerol accumulation and cannabinoid CB1 receptor activity in rat brain cryosections by functional autoradiography

Palomäki, V., Lehtonen, M., Savinainen, J. R., & Laitinen, J. T. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04403.x · Cited by 32

Neuroprotection and Beyond: The Central Role of CB1 and CB2 Receptors in Stroke Recovery

Bietar, B., Tanner, S., & Lehmann, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316728 · Cited by 32

Endocannabinoid system and its modulation of brain, gut, joint and skin inflammation

Osafo, N., Yeboah, K. O., & Antwi, A. O. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06366-1 · Cited by 35

Cannabinoids as anticancer and neuroprotective drugs: Structural insights and pharmacological interactions—A review

Pugazhendhi, A., Suganthy, N., Chau, T. P., Sharma, A. K., Unpaprom, Y., Ramaraj, R., Karuppusamy, I., & Brindhadevi, K. (2021) · Process Biochemistry · doi:10.1016/j.procbio.2021.08.025 · Cited by 32

The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis

Baker, D., Pryce, G., Jackson, S. J., Bolton, C., & Giovannoni, G. (2012) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2011.11.001 · Cited by 31

Cannabinoid System in Neurodegeneration: New Perspectives in Alzheimers Disease

Campillo, N. E., & Paez, J. A. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709788167628 · Cited by 31

Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis

Porter, R. F., Szczesniak, A.-M., Toguri, J. T., Gebremeskel, S., Johnston, B., Lehmann, C., Fingerle, J., Rothenhäusler, B., Perret, C., Rogers‐Evans, M., et al. (2019) · Molecules · doi:10.3390/molecules24183338 · Cited by 30

The 15-Deoxy-Δ12,14-Prostaglandin J2 Suppresses Monocyte Chemoattractant Protein-1 Expression in IFN-γ-Stimulated Astrocytes through Induction of MAPK Phosphatase-1

Lee, J. H., Woo, J. H., Woo, S. U., Kim, K. S., Park, S. M., Joe, E.-H., & Jou, I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8642 · Cited by 30

Opposite effects of anandamide andn‐arachidonoyl dopamine in the regulation of prostaglandin E2and 8‐iso‐PGF2αformation in primary glial cells

Navarrete, C. M., Fiebich, B. L., de Vinuesa, A. G., Hess, S., de Oliveira, A. C. P., Candelario‐Jalil, E., Caballero, F. J., Calzado, M. A., & Muñóz, E. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05966.x · Cited by 30

The arguments for and against cannabinoids application in glaucomatous retinopathy

Panahi, Y., Manayi, A., Nikan, M., & Vazirian, M. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.106 · Cited by 29

Cannabinoids Affect Dendritic Cell (DC) Potassium Channel Function and Modulate DC T Cell Stimulatory Capacity

Wacnik, P. W., Luhr, K. M., Hill, R. H., Ljunggren, H., Kristensson, K., & Svensson, M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3057 · Cited by 29

Potentiation of microglial endocannabinoid signaling alleviates neuroinflammation in Alzheimer's disease

Rapaka, D., Bitra, V. R., Challa, S. R., & Adiukwu, P. C. (2021) · Neuropeptides · doi:10.1016/j.npep.2021.102196 · Cited by 29

Neuroinflammation as a possible link between cannabinoids and addiction

Rodrigues, L. C. M., Gobira, P. H., de Oliveira, A. C., Pelição, R., Teixeira, A. L., Moreira, F. A., & Campos, A. C. (2013) · Acta Neuropsychiatrica · doi:10.1017/neu.2014.24 · Cited by 29

Inflammation and aging: Can endocannabinoids help?

Marchalant, Y., Brothers, H. M., & Wenk, G. L. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.02.004 · Cited by 27

Cannabinoid receptors and TRPA1 on neuroprotection in a model of retinal ischemia

de Araújo, D. S. M., Miya-Coreixas, V. S., Pandolfo, P., & Calaza, K. D. C. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.11.015 · Cited by 31

Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases

Meanti, R., Bresciani, E., Rizzi, L., Molteni, L., Coco, S., Omeljaniuk, R. J., & Torsello, A. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118044 · Cited by 30

Cannabidiol attenuates delayed-type hypersensitivity reactions via suppressing T-cell and macrophage reactivity

Liu, D.-Z., Hu, C.-M., Huang, C.-H., Wey, S., & Jan, T. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.155 · Cited by 28

Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters

Sexton, M., Cudaback, E., Abdullah, R. A., Finnell, J. S., Mischley, L. K., Rozga, M., Lichtman, A. H., & Stella, N. (2014) · Inflammopharmacology · doi:10.1007/s10787-014-0214-z · Cited by 28

The (Endo)Cannabinoid System in Multiple Sclerosis and Amyotrophic Lateral Sclerosis

Centonze, D., Rossi, S., Finazzi‐Agrò, A., Bernardi, G., & Maccarrone, M. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)82009-5 · Cited by 29

Endogenous cannabinoid anandamide inhibits nicotinic acetylcholine receptor function in mouse thalamic synaptosomes

Butt, C. M., Alptekin, A., Shippenberg, T., & Oz, M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05225.x · Cited by 29

Single-cell transcriptomics identifies premature aging features of TERC-deficient mouse brain and bone marrow

Yang, C., Pang, Y., Huang, Y., Ye, F., Chen, X., Gao, Y., Zhang, C., Yao, L., & Gao, J. (2022) · GeroScience · doi:10.1007/s11357-022-00578-4 · Cited by 28

The role of endocannabinoids in the regulation of luteinizing hormone and prolactin release

Oláh, M., Milloh, H., & Wenger, T. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.01.005 · Cited by 27

The decrease of dopamine D2/D3 receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB1 cannabinoid receptors in Parkinson's disease: A preliminary autoradiographic study with the selective dopamine D2/D3 antagonist [3H]raclopride and the novel CB1 inverse agonist [125I]SD7015

Farkas, S., Nagy, K., Jia, Z., Harkany, T., Palkovits, M., Donohou, S. R., Pike, V. W., Halldin, C., Máthé, D., Csiba, L., et al. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.02.012 · Cited by 26

The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain

Ramil, E., Sánchez, A., González-Pérez, P., Antigüedad, A. R., Gómez‐Lozano, N., Ortiz, P., Arroyo, R., Heras, V. D. L., Vilches, C., & Garcı́a-Merino, A. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509355071 · Cited by 27

Cannabidiol as an immune modulator: A comprehensive review

Mujahid, K., Rasheed, M. S., Sabir, A., Nam, J., Ramzan, T., Ashraf, W., & Imran, I. (2025) · Saudi Pharmaceutical Journal · doi:10.1007/s44446-025-00005-7 · Cited by 31

Cannabinoids to treat spinal cord injury

Arévalo‐Martín, Á., Molina‐Holgado, E., & García‐Ovejero, D. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.03.008 · Cited by 27

Cannabinoids in Microglia: A New Trick for Immune Surveillance and Neuroprotection

Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2005.12.004 · Cited by 26

The endocannabinoid N-arachidonoyldopamine (NADA) exerts neuroprotective effects after excitotoxic neuronal damage via cannabinoid receptor 1 (CB1)

Grabiec, U., Koch, M., Kallendrusch, S., Kraft, R., Hill, K., Merkwitz, C., Ghadban, C., Lutz, B., Straiker, A. J., & Dehghani, F. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.11.023 · Cited by 25

Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis

Manterola, A., Bernal‐Chico, A., Cipriani, R., Ruiz, A., Pérez‐Samartín, A., Moreno‐Rodríguez, M., Hsu, K., Cravatt, B. F., Brown, J. M., Rodríguez‐Puertas, R., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.08.038 · Cited by 25

Epigenetic Regulation of Cannabinoid-Mediated Attenuation of Inflammation and Its Impact on the Use of Cannabinoids to Treat Autoimmune Diseases

Holloman, B. L., Nagarkatti, M., & Nagarkatti, P. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147302 · Cited by 27

Neuroinflammation in the Central Nervous System: Exploring the Evolving Influence of Endocannabinoid System

Rathod, S., Agrawal, Y. O., Nakhate, K. T., Meeran, M. F. N., Ojha, S. K., & Goyal, S. N. (2023) · Biomedicines · doi:10.3390/biomedicines11102642 · Cited by 25

Chapter 9 The Endocannabinoid Anandamide

Correa, F., Mestre, L., Docagne, F., Borrell, J. I., & Guaza, C. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(09)81009-1 · Cited by 24

Cannabinoid and endocannabinoid system: a promising therapeutic intervention for multiple sclerosis

Khan, H., Ghori, F. K., Ghani, U., Javed, A., & Zahid, S. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07223-5 · Cited by 24

Phosphatidylethanolamine Deficiency and Triglyceride Overload in Perilesional Cortex Contribute to Non-Goal-Directed Hyperactivity after Traumatic Brain Injury in Mice

Hahnefeld, L., Vogel, A., Gurke, R., Geißlinger, G., Schäfer, M. K. E., & Tegeder, I. (2022) · Biomedicines · doi:10.3390/biomedicines10040914 · Cited by 23

Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic Rats

Spyridakos, D., Mastrodimou, N., Vemuri, K. V., Ho, T. C., Nikas, S. P., Makriyannis, A., & Thermos, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010240 · Cited by 23

The (AAT) n repeat of the cannabinoid CB 1 receptor gene influences disease progression in relapsing multiple sclerosis

Rossi, S., Buttari, F., Studer, V., Motta, C., Gravina, P., Castelli, M., Mantovani, V., Chiara, V. D., Musella, A., Fiore, S., et al. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510388680 · Cited by 23

The endocannabinoid system in canine Steroid-Responsive Meningitis-Arteritis and Intraspinal Spirocercosis

Freundt-Revilla, J., Heinrich, F., Zoerner, A. A., Gesell, F. K., Beyerbach, M., Shamir, M. H., Oevermann, A., Baumgärtner, W., & Tipold, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0187197 · Cited by 24

The endocannabinoid system in gp120-mediated insults and HIV-associated dementia

Bari, M., Rapino, C., Mozetic, P., & Maccarrone, M. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.03.025 · Cited by 23

Inverse agonism of cannabinoid CB1 receptor blocks the adhesion of encephalitogenic T cells in inflamed brain venules by a protein kinase A-dependent mechanism

Rossi, B., Zenaro, E., Angiari, S., Ottoboni, L., Bach, S., Piccio, L. M., Pietronigro, E. C., Scarpini, E. A., Fusco, M., Leon, A., et al. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.12.005 · Cited by 22

The role of Cannabidiol and tetrahydrocannabivarin to overcome doxorubicin resistance in MDA-MB-231 xenografts in athymic nude mice

Kalvala, A. K., Nimma, R., Bagde, A., Surapaneni, S. K., Patel, N., Arthur, P., Sun, L. J., Singh, R. K., Kommineni, N., Nathani, A., et al. (2022) · Biochimie · doi:10.1016/j.biochi.2022.12.008 · Cited by 22

Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease

Gómez-Pascual, A., Naccache, T., Xu, J., Hooshmand, K., Wretlind, A., Gabrielli, M., Lombardo, M. T., Shi, L., Buckley, N. J., Tijms, B. M., et al. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108588 · Cited by 23

Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against LPS-Induced Impairments in Rat Caudate Nucleus

Lu, Y., Peng, F., Dong, M., & Yang, H. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0246-2 · Cited by 22

5, 8, 11, 14-eicosatetraynoic acid suppresses CCL2/MCP-1 expression in IFN-γ-stimulated astrocytes by increasing MAPK phosphatase-1 mRNA stability

Lee, J. H., Kim, H., Woo, J. H., Joe, E.-H., & Jou, I. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-34 · Cited by 22

Anti-inflammatory and immunomodulatory strategies to protect the perinatal brain

Wolfberg, A., Dammann, O., & Gressèns, P. (2007) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2007.01.021 · Cited by 22

Aplicaciones de los cannabinoides en glaucoma

Pinar‐Sueiro, S., Rodríguez‐Puertas, R., & Vecino, E. (2011) · Archivos de la Sociedad Española de Oftalmología · doi:10.1016/j.oftal.2010.11.015 · Cited by 21

FAAH served a key membrane-anchoring and stabilizing role for NLRP3 protein independently of the endocannabinoid system

Zhu, Y., Zhang, H., Mao, H., Zhong, S., Huang, Y., Chen, S., Yan, K., Zhao, Z., Hao, X., Zhang, Y., et al. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-01054-4 · Cited by 23

Involvement of nitric oxide through endocannabinoids release in microglia activation during the course of CNS regeneration in the medicinal leech

Arafah, K., Croix, D., Vizioli, J., Desmons, A., Fournier, I., & Salzet, M. (2013) · Glia · doi:10.1002/glia.22462 · Cited by 21

Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer’s Disease and Less Well-Known Diseases

Paez, J. A., & Campillo, N. E. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180226095132 · Cited by 20

Cannabinoid System and Neuroinflammation: Implications for Multiple Sclerosis

Correa, F., Docagne, F., Mestre, L., Loría, F., Hernangómez, M., Borrell, J. I., & Guaza, C. (2007) · NeuroImmunoModulation · doi:10.1159/000110644 · Cited by 21

Cannabinoid applications in glaucoma

Pinar‐Sueiro, S., Rodríguez‐Puertas, R., & Vecino, E. (2011) · Archivos de la Sociedad Española de Oftalmología (English Edition) · doi:10.1016/s2173-5794(11)70004-4 · Cited by 20

Therapeutic Attributes of Endocannabinoid System against Neuro-Inflammatory Autoimmune Disorders

Ahmed, I., Rehman, S. U., Shahmohamadnejad, S., Zia, M. A., Ahmad, M. M., Saeed, M. M., Akram, Z., Iqbal, H. M. N., & Liu, Q. (2021) · Molecules · doi:10.3390/molecules26113389 · Cited by 20

Early graft of neural precursors in spinal cord compression reduces glial cyst and improves function

Boido, M., Garbossa, D., & Vercelli, A. (2011) · Journal of Neurosurgery Spine · doi:10.3171/2011.1.spine10607 · Cited by 20

Cannabinoid 1 receptor signaling on GABAergic neurons influences astrocytes in the ageing brain

Bilkei‐Gorzó, A., Albayram, Ö., Ativie, F., Chasan, S., Zimmer, T. S., Bach, K., & Zimmer, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202566 · Cited by 20

Δ9‐Tetrahydrocannabinol promotes functional remyelination in the mouse brain

Aguado, T., Huerga-Gómez, A., Torre, A. S.-D. L., Resel, E., Chara, J. C., Matute, C., Mato, S., Galve‐Roperh, I., Guzmán, M., & Palazuelos, J. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15608 · Cited by 20

Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances

Smith, P. F. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.9.1157 · Cited by 20

Enhanced microglial activity in FAAH−/− animals

Ativie, F., Albayram, Ö., Bach, K., Pradier, B., Zimmer, A., & Bilkei‐Gorzó, A. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.12.016 · Cited by 20

MAP kinase cascades regulating axon regeneration in C. elegans

Pastuhov, S. I., Hisamoto, N., & Matsumoto, K. (2015) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.91.63 · Cited by 19

Cannabinoids, multiple sclerosis and neuroprotection

de Lago, E., Gómez‐Ruíz, M., Moreno‐Martet, M., & Fernández‐Ruíz, J. (2009) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.09.42 · Cited by 19

Abnormal Cannabidiol Affects Production of Pro-Inflammatory Mediators and Astrocyte Wound Closure in Primary Astrocytic-Microglial Cocultures

von Widdern, J. C., Hohmann, T., & Dehghani, F. (2020) · Molecules · doi:10.3390/molecules25030496 · Cited by 19

Autoimmune inflammation triggers aberrant astrocytic calcium signaling to impair synaptic plasticity

Baraibar, A. M., Colomer, T., Moreno‐García, A., Bernal‐Chico, A., Sánchez-Martín, E., Utrilla, C., Serrat, R., Gómez, E. S., Rodríguez-Antigüedad, A., Araque, A., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.07.010 · Cited by 18

Chapter 11 Glucocorticoid‐Regulated Crosstalk Between Arachidonic Acid and Endocannabinoid Biochemical Pathways Coordinates Cognitive‐, Neuroimmune‐, and Energy Homeostasis‐Related Adaptations to Stress

Malcher‐Lopes, R., & Buzzi, M. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(09)81011-x · Cited by 19

Immunomodulatory Properties of Kappa Opioids and Synthetic Cannabinoids in HIV-1 Neuropathogenesis

Hu, S., Sheng, W. S., & Rock, R. B. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9306-3 · Cited by 18

Site-Specific and Time-Dependent Activation of the Endocannabinoid System after Transection of Long-Range Projections

Kallendrusch, S., Hobusch, C., Ehrlich, A., Ziebell, S., Ueda, N., Geißlinger, G., Koch, M., & Dehghani, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033537 · Cited by 18

Endocannabinoid 2-arachidonoylglycerol protects inflammatory insults from sulfur dioxide inhalation via cannabinoid receptors in the brain

Li, B., Chen, M., Guo, L., Yun, Y., Li, G., & Sang, N. (2016) · Journal of Environmental Sciences · doi:10.1016/j.jes.2016.05.031 · Cited by 18

Protective actions of vitamin D, anandamide and melatonin during vascular inflammation: Epigenetic mechanisms involved

Giménez, V. M. M., Chuffa, L. G. D. A., Simão, V. A., Reiter, R. J., & Manucha, W. A. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120191 · Cited by 17

Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions

Papa, A., Pasquini, S., Galvani, F., Cammarota, M., Contri, C., Carullo, G., Gemma, S., Ramunno, A., Lamponi, S., Gorelli, B., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114952 · Cited by 17

Effect of acute and subchronic administration of (R)-WIN55,212-2 induced neuroprotection and anti inflammatory actions in rat retina: CB1 and CB2 receptor involvement

Spyridakos, D., Papadogkonaki, S., Dionysopoulou, S., Mastrodimou, N., Polioudaki, H., & Thermos, K. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104907 · Cited by 17

Cannabinoids in Microglia: A New Trick for Immune Surveillance and Neuroprotection

Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2005.12.004 · Cited by 26

Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies

Vázquez, C., Tolón, R. M., Pazos, M. R., Moreno, M., Koester, E. C., Cravatt, B. F., Hillard, C. J., & Romero, J. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.005 · Cited by 42

CD200‐CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation

Hernangómez, M., Mestre, L., Correa, F., Loría, F., Mecha, M., Iñigo, P. M., Docagne, F., Williams, R. O., Borrell, J. I., & Guaza, C. (2012) · Glia · doi:10.1002/glia.22366 · Cited by 130

Neuroprotective effect of endogenous cannabinoids on ischemic brain injury induced by the excess microglia-mediated inflammation.

Guo, S., Liu, Y., Ma, R., Li, J., & Su, B. (2016) · Europe PMC (PubMed Central) · Cited by 11

P.3.f.002 CNS infections during childhood and risk for schizophrenia: a case control study

Halperin, D. S., Davidson, M., Werbeloff, N., Yoffe, R., Levine, A., Livni, G., & Weiser, M. (2008) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(08)70707-7